Homepage
Author:
Metabolon, Inc.
Posted Date:
February 17, 2026
Metabolon’s Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity
Metabolon, Inc.
February 17, 2026
Metabolon Names Andrew Messick Chief Financial Officer
Metabolon, Inc.
February 3, 2026